PortfoliosLab logoPortfoliosLab logo
AAPL vs. NVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AAPL vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Apple Inc (AAPL) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AAPL achieves a 20.35% return, which is significantly higher than NVS's 11.78% return. Over the past 10 years, AAPL has outperformed NVS with an annualized return of 30.70%, while NVS has yielded a comparatively lower 9.95% annualized return.


AAPL

1D
-2.14%
1M
9.59%
6M
28.05%
YTD
20.35%
1Y
55.26%
3Y*
19.94%
5Y*
18.17%
10Y*
30.70%
ALL TIME*
19.46%

NVS

1D
-2.73%
1M
1.69%
6M
6.77%
YTD
11.78%
1Y
34.89%
3Y*
16.47%
5Y*
14.79%
10Y*
9.95%
ALL TIME*
8.95%
*Multi-year figures are annualized to reflect compound growth (CAGR)

AAPL vs. NVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AAPL
Apple Inc
20.35%9.05%30.71%49.01%-26.40%34.65%82.31%88.96%-5.39%48.46%
NVS
Novartis AG
11.78%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%

Correlation

The correlation between AAPL and NVS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.20

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Nov 7, 1996

0.22

The correlation between AAPL and NVS shifts across timeframes, from 0.12 (3 years) to 0.24 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AAPL:

$4.80T

NVS:

$285.37B

EPS

AAPL:

$8.25

NVS:

$7.02

PE Ratio

AAPL:

39.60

NVS:

21.31

PEG Ratio

AAPL:

5.21

NVS:

1.44

PS Ratio

AAPL:

10.75

NVS:

5.15

PB Ratio

AAPL:

45.29

NVS:

7.44

Total Revenue (TTM)

AAPL:

$451.44B

NVS:

$56.05B

Gross Profit (TTM)

AAPL:

$216.07B

NVS:

$42.19B

EBITDA (TTM)

AAPL:

$153.63B

NVS:

$22.40B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AAPL vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AAPL
AAPL Risk / Return Rank: 9292
Overall Rank
AAPL Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
AAPL Sortino Ratio Rank: 9393
Sortino Ratio Rank
AAPL Omega Ratio Rank: 9393
Omega Ratio Rank
AAPL Calmar Ratio Rank: 9292
Calmar Ratio Rank
AAPL Martin Ratio Rank: 9090
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 8585
Overall Rank
NVS Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 8484
Sortino Ratio Rank
NVS Omega Ratio Rank: 8282
Omega Ratio Rank
NVS Calmar Ratio Rank: 8585
Calmar Ratio Rank
NVS Martin Ratio Rank: 8484
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

AAPL vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Apple Inc (AAPL) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AAPLNVSDifference
Sharpe ratioReturn per unit of total volatility

+0.63

Sortino ratioReturn per unit of downside risk

+0.78

Omega ratioGain probability vs. loss probability

1.41

1.28

+0.12

Calmar ratioReturn relative to maximum drawdown

4.02

2.77

+1.25

Martin ratioReturn relative to average drawdown

9.58

6.58

+3.00

AAPL vs. NVS - Sharpe Ratio Comparison

The current AAPL Sharpe Ratio is 2.27, which is higher than the NVS Sharpe Ratio of 1.63. The chart below compares the historical Sharpe Ratios of AAPL and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AAPL vs. NVS - Drawdown Comparison

The maximum AAPL drawdown since its inception was -81.80%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for AAPL and NVS.


Loading charts...

Drawdown Indicators


AAPLNVSDifference

Max Drawdown

Largest peak-to-trough decline

-81.80%

-42.10%

-39.70%

Max Drawdown (1Y)

Largest decline over 1 year

-13.80%

-12.65%

-1.15%

Max Drawdown (3Y)

Largest decline over 3 years

-33.36%

-19.95%

-13.41%

Max Drawdown (5Y)

Largest decline over 5 years

-33.36%

-20.42%

-12.94%

Max Drawdown (10Y)

Largest decline over 10 years

-38.52%

-26.03%

-12.49%

Current Drawdown

Current decline from peak

-2.14%

-8.60%

+6.46%

Average Drawdown

Average peak-to-trough decline

-29.54%

-10.91%

-18.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.78%

5.31%

+0.47%

Volatility

AAPL vs. NVS - Volatility Comparison

Apple Inc (AAPL) has a higher volatility of 10.61% compared to Novartis AG (NVS) at 8.03%. This indicates that AAPL's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AAPLNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.61%

8.03%

+2.58%

Volatility (6M)

Calculated over the trailing 6-month period

19.34%

15.98%

+3.36%

Volatility (1Y)

Calculated over the trailing 1-year period

24.55%

21.51%

+3.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.79%

19.18%

+8.61%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

29.08%

19.69%

+9.39%

Dividends

AAPL vs. NVS - Dividend Comparison

AAPL's dividend yield for the trailing twelve months is around 0.32%, less than NVS's 3.19% yield.


PositionTTM20252024202320222021202020192018201720162015
AAPL
Apple Inc
0.32%0.38%0.40%0.49%0.70%0.49%0.61%1.04%1.79%1.45%1.93%1.93%
NVS
Novartis AG
3.19%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Financials

AAPL vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between Apple Inc and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


20.00B40.00B60.00B80.00B100.00B120.00B140.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
111.18B
13.52B
(AAPL) Total Revenue
(NVS) Total Revenue
Values in USD except per share items

AAPL vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between Apple Inc and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
49.3%
74.4%
Portfolio components
AAPL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Apple Inc reported a gross profit of 54.78B and revenue of 111.18B. Therefore, the gross margin over that period was 49.3%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.

AAPL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Apple Inc reported an operating income of 35.89B and revenue of 111.18B, resulting in an operating margin of 32.3%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.

AAPL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Apple Inc reported a net income of 29.58B and revenue of 111.18B, resulting in a net margin of 26.6%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.


Frequently Asked Questions


AAPL and NVS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AAPL has higher volatility (10.61%) compared to NVS (8.03%). In terms of maximum drawdown, AAPL dropped -81.80% vs NVS's -42.10%.

AAPL currently has the higher Sharpe Ratio (2.27 vs 1.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AAPL and NVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer